Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation
- 24 July 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (16) , 9260-9264
- https://doi.org/10.1073/pnas.161294898
Abstract
Arginase, which exists as the isoforms arginase I and II, catalyzes the hydrolysis of arginine to ornithine and urea. Ornithine is the principal precursor for production of polyamines, which are required for cell proliferation. Rat aortic smooth muscle cells (RASMC) contain constitutive arginase I, and arginase inhibitors cause inhibition of cell proliferation. The objective of this study was to determine whether the elevated expression of arginase I in RASMC causes increased cell proliferation. RASMC were stably transfected with either rat arginase I cDNA or a beta-galactosidase control expression plasmid. Western blots and arginase enzymatic assays revealed high-level expression of cytosolic arginase I in arginase I-transfected RASMC. Moreover, this observation was associated with the increased production of urea and polyamines and higher rates of RASMC proliferation. The two selective inhibitors of arginase, N(G)-hydroxy-l-arginine and S-(2-boronoethyl)-l-cysteine, inhibited arginase and decreased the production of urea and polyamines in arginase I-transfected RASMC, all of which were associated with the inhibition of cell proliferation. This study demonstrates that elevated arginase I expression increases RASMC proliferation by mechanisms involving increased production of polyamines. These observations suggest that arginase I plays a potentially important role in controlling RASMC proliferation.Keywords
This publication has 21 references indexed in Scilit:
- Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferationProceedings of the National Academy of Sciences, 2001
- Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applicationsCellular and Molecular Life Sciences, 2001
- Nitric Oxide Inhibits Ornithine Decarboxylase by S-NitrosylationBiochemical and Biophysical Research Communications, 1999
- Regulation of gene expression, growth, and cell survival by IL-4: Contribution of multiple signaling pathwaysCell Research, 1998
- Comparative properties of arginasesComparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Ornithine decarboxylase: A biochemical marker of repair in damaged tissueLife Sciences, 1991
- Identification of residues in ornithine decarboxylase essential for enzymic activity and for rapid protein turnoverBiochemical Journal, 1991
- Polyamines: from Molecular Biology to Clinical ApplicationsAnnals of Medicine, 1991
- NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein.Proceedings of the National Academy of Sciences, 1990